Dg Health Cold Zone Pain Relieving

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including conditions such as simple backache, arthritis, strains, bruises, and sprains. It is specifically indicated for the management of arthritis, backache, muscle pain, and joint pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 6 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

Children under 6 years of age should not use this product. Healthcare professionals are advised to monitor the application in patients within the approved age range to ensure compliance with the recommended dosing guidelines.

Contraindications

The product is contraindicated for application to wounds or damaged skin due to the potential for irritation or adverse effects. Additionally, it should not be bandaged tightly, as this may impede circulation. The use of heating pads or other heating devices in conjunction with this product is also contraindicated, as it may lead to increased absorption and potential toxicity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with the eyes when using this product. It is imperative that the product is not applied to wounds or damaged skin, and that it is not bandaged tightly. Additionally, the use of heating pads or other heating devices in conjunction with this product is contraindicated.

Patients should be instructed to discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

This product is flammable; therefore, it must be kept away from fire or flame. It is essential to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

For individuals who are pregnant or breastfeeding, consultation with a healthcare professional is recommended prior to use.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only and should not come into contact with the eyes. Application to wounds or damaged skin is contraindicated, and the product should not be bandaged tightly or used in conjunction with heating pads or other heating devices.

In the event that the condition worsens, or if symptoms persist for more than 7 days or resolve and then recur within a few days, patients are advised to stop use and consult a healthcare professional.

Additionally, the product is flammable; therefore, it should be kept away from fire or flame. Pregnant or breastfeeding individuals should seek advice from a health professional prior to use.

It is crucial to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center (1-800-222-1222) is recommended.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dg Health Cold Zone Pain Relieving (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not use this medication. For children aged 6 years and older, the recommended application is to the affected area no more than 3-4 times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as there is no available data to guide treatment decisions in this population. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. Contacting a Poison Control Center at 1-800-222-1222 is recommended for guidance on appropriate actions to take.

It is essential to monitor for potential symptoms of overdosage, which may vary depending on the specific substance involved. Healthcare providers should be prepared to assess the patient for any signs of toxicity and initiate appropriate management procedures based on the clinical presentation.

Prompt intervention and adherence to established protocols are vital in mitigating the effects of an overdosage and ensuring patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, patients must be cautioned to avoid contact with their eyes. They should not apply the product to wounds or damaged skin, and they should refrain from bandaging the area tightly. Additionally, patients should be advised against using the product in conjunction with heating pads or other heating devices.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Care should be taken to keep the product away from fire or flame to prevent any hazards. Additionally, it is crucial to keep the product out of reach of children to ensure safety. Once opened, the product should be discarded to avoid any potential risks associated with prolonged exposure.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 6 years and older. It is contraindicated for use in children under 6 years of age. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dg Health Cold Zone Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)